1CP
LLY icon

17 Capital Partners’s Eli Lilly LLY Stock Holding History

17 Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$642K Buy
698
+505
+262% +$512K 0.33% 100
2025
Q4 		$207K Buy
+193
New +$185K 0.11% 155

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

17 Capital Partners's LLY Position: Q1 2026 in Review

17 Capital Partners increased its Eli Lilly (LLY) stake by 262% in Q1 2026, buying an estimated $512K and bringing the position to 698 shares worth $642K. The position accounts for 0.33% of the portfolio, ranked #100.

17 Capital Partners first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • 17 Capital Partners held 698 shares of Eli Lilly worth $642K as of Q1 2026.
  • 17 Capital Partners bought 505 Eli Lilly shares in Q1 2026, an estimated $512K.
  • Eli Lilly made up 0.33% of 17 Capital Partners's portfolio in Q1 2026, its #100 holding.
  • 17 Capital Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on 17 Capital Partners's 13F filing for Q1 2026, filed 13 May 2026.